W35 Lagos stats & predictions

Morning Matches

The day begins with several exciting matches. One of the highlights is the clash between Maria Sakkari and Karolina Pliskova. This match promises to be a tactical battle, with both players known for their strategic acumen.

• Sakkari vs Pliskova: A match that could go either way, with Sakkari's consistency on clay pitted against Pliskova's powerful serve.
• Sabalenka vs Julia Goerges: Sabalenka's power versus Goerges' experience could make for an intriguing contest.

Afternoon Matches

The afternoon lineup features equally compelling matchups. One of the key encounters is between Paula Badosa and Elise Mertens. Both players have shown remarkable form recently, setting the stage for an intense showdown.

• Badosa vs Mertens: A battle of youth versus experience, with Badosa's aggressive playstyle challenging Mertens' tactical prowess.
• Anett Kontaveit vs Petra Kvitova: Kontaveit's consistency meets Kvitova's flair, promising an exciting match.

Maria Sakkari

Sakkari has been in excellent form recently, particularly on clay courts. Her powerful baseline game and mental toughness make her a formidable opponent. Key strengths include her ability to dictate play from the backcourt and her resilience under pressure.

• Strengths: Powerful groundstrokes, strong mental game, excellent movement on clay.
• Weakeness: Occasionally struggles with unforced errors under pressure.

Karolina Pliskova

Pliskova's serve is one of the best in women's tennis. Her aggressive playing style can overwhelm opponents if she gets into a rhythm early in matches. However, her performance can be inconsistent if she fails to maintain her serve accuracy.

• Strengths: Dominant serve, aggressive baseline play, strong mental resilience.
• Weakeness: Can struggle against players with strong return games if her serve drops off.

Aryna Sabalenka

Sabalenka's game is characterized by her raw power and athleticism. Her ability to hit winners from both wings makes her a constant threat. However, her lack of experience in high-stakes matches can sometimes be a disadvantage.

• Strengths: Powerful groundstrokes, excellent athleticism, ability to hit winners from any position.
• Weakeness: Inconsistent mental game under pressure, can struggle with tactical adjustments.

Sakkari vs Pliskova: Tactical Breakdown</h4

This matchup will likely hinge on who can impose their game plan more effectively. Sakkari's strategy may involve using her strong baseline game to keep Pliskova at bay while looking for opportunities to approach the net when possible. Pliskova will aim to use her powerful serve to gain free points and dictate play from the baseline with aggressive shot-making.

<ul 1: # Treatment outcomes among patients with schizophrenia treated at outpatient psychiatric clinics: protocol for a systematic review 2: Author: Sean Yap Chin Cheng 3: Date: 8-14-2019 4: Link: https://doi.org/10.1186/s13643-019-1099-7 5: Systematic Reviews: Protocol 6: ## Abstract 7: BackgroundSchizophrenia is one of the most disabling psychiatric disorders worldwide with patients suffering from impaired cognition or thought processes that lead them to experience hallucinations or delusions that may cause them harm or social isolation due to inappropriate behavior or speech that further aggravates their condition by causing them distress or disability. 8: The aim of this systematic review is therefore to identify studies that reported treatment outcomes among patients with schizophrenia treated at outpatient psychiatric clinics. 9: MethodsThis systematic review will follow guidelines set out by PRISMA (Preferred Reporting Items for Systematic Reviews) statement checklist. 10: The search will be conducted using electronic databases including MEDLINE (Ovid), EMBASE (Ovid), PsycINFO (Ovid), CINAHL (EBSCOhost), AMED (Ovid) as well as Cochrane Central Register of Controlled Trials (CENTRAL). Grey literature sources will also be searched using OpenGrey database. 11: Included studies will include randomized controlled trials (RCTs), non-randomized controlled trials (non-RCTs), prospective cohort studies (PCS) or retrospective cohort studies (RCS) that were published in English language only from year January 1st 2000 onwards till date. 12: Two independent reviewers will screen titles/abstracts followed by full-text articles identified as potentially relevant studies using inclusion criteria outlined above against PRISMA flow diagram. 13: Data extraction will be performed independently by two reviewers using standardized data extraction forms developed by authors before any disagreements resolved by consensus or discussion with third reviewer. 14: Data analysis will be performed according to type of study design identified using statistical software Stata version 15. 15: DiscussionThe results from this systematic review may inform future research directions by identifying gaps in knowledge related treatment outcomes among patients with schizophrenia treated at outpatient psychiatric clinics. 16: ConclusionThis systematic review aims to identify studies that reported treatment outcomes among patients with schizophrenia treated at outpatient psychiatric clinics. 17: ## Background 18: Schizophrenia is one of the most disabling psychiatric disorders worldwide [1]. It affects about one percent of population worldwide [2]. Schizophrenia patients suffer from impaired cognition or thought processes that lead them experience hallucinations or delusions that may cause them harm or social isolation due to inappropriate behavior or speech [1]. 19: The onset of schizophrenia typically occurs during late adolescence or early adulthood [2]. In developing countries such as Malaysia where this study was conducted there are limited mental health services available compared developed countries [3]. This means that many people who need help do not get it because they cannot afford private treatment costs which leaves only government hospitals providing free services but these hospitals are often overcrowded resulting long waiting lists so many patients end up being untreated until symptoms become severe enough requiring hospitalization which further exacerbates stigma associated with mental illness making it harder for people suffering from schizophrenia seek help when needed leading cycle poverty unemployment homelessness substance abuse criminal activity suicide attempts etcetera all common consequences untreated severe mental illness especially among young people whose lives disrupted early onset disease before reaching full potential education employment relationships family life etcetera 20: ### Rationale 21: Schizophrenia patients have impaired cognition which leads them experience hallucinations or delusions that may cause them harm or social isolation due inappropriate behavior speech further aggravating condition distress disability [1]. 22: There are many treatments available for schizophrenia including medications antipsychotics cognitive behavioral therapy psychosocial rehabilitation vocational training supported employment family interventions case management assertive community treatment clubhouse model recovery model peer support groups etcetera [1]. 23: The aim of this systematic review therefore identify studies reported treatment outcomes among patients schizophrenia treated outpatient psychiatric clinics. 24: ## Methods/design 25: ### Protocol registration 26: This protocol was registered prospectively at PROSPERO database under registration number CRD42018116494. 27: ### Eligibility criteria 28: #### Types of studies 29: All randomized controlled trials (RCTs), non-randomized controlled trials (non-RCTs), prospective cohort studies (PCS) or retrospective cohort studies (RCS) published from year January 1st 2000 onwards till date will be included. 30: #### Participants/population 31: Patients diagnosed with schizophrenia based on Diagnostic Statistical Manual version IV text revision criteria DSM-IV-TR published by American Psychiatric Association APA [4] International Classification Diseases version ten criteria ICD-10 published by World Health Organization WHO [5] regardless gender age race ethnicity religion socioeconomic status marital status employment status etcetera will be included. 32: #### Interventions/exposures 33: All interventions/exposures related treating managing schizophrenia patients treated at outpatient psychiatric clinics regardless type duration frequency intensity setting provider etcetera will be included. 34: #### Comparators/control groups 35: All comparators/control groups used comparing effectiveness safety tolerability cost-effectiveness acceptability feasibility appropriateness relevance usefulness applicability generalizability transferability sustainability scalability replicability etcetera interventions/exposures related treating managing schizophrenia patients treated at outpatient psychiatric clinics regardless type duration frequency intensity setting provider etcetera will be included. 36: #### Outcomes 37: All outcomes related treatment outcomes among patients with schizophrenia treated at outpatient psychiatric clinics regardless type duration frequency intensity setting provider etcetera will be included. 38: ### Information sources 39: The search strategy was developed using MeSH terms (“schizophrenia”[MeSH Terms] OR “psychosis”[MeSH Terms]) AND (“treatment outcome”[MeSH Terms] OR “treatment outcome”[All Fields]) AND (“outpatient”[MeSH Terms] OR “outpatient”[All Fields]) AND (“clinic*”[All Fields]) AND (“study”[All Fields] OR “studies”[All Fields]).The search will be conducted using electronic databases including MEDLINE (Ovid), EMBASE (Ovid), PsycINFO (Ovid), CINAHL (EBSCOhost), AMED (Ovid) as well as Cochrane Central Register of Controlled Trials (CENTRAL). 40: Grey literature sources will also be searched using OpenGrey database http://www.opengrey.eu/. 41: ### Search strategy 42: An example search strategy used MEDLINE via Ovid is shown below: 43: *Schizophrenia AND Treatment Outcome AND Outpatient AND Clinic* AND Study* Search date = 26th June 2018. 44: *#1 exp Schizophrenia/ 45: *#2 exp Schizoaffective Disorder/ 46: *#3 exp Psychosis/ 47: *#4 exp Mental Disorders/ 48: *#5 exp Psychiatric Disorders/ 49: *#6 Schizophrenia.ti.,ab.,kw. 50: *#7 Psychosis.ti.,ab.,kw. 51: *#8 Mental Disorders.ti.,ab.,kw. 52: *#9 Psychiatric Disorder.ti.,ab.,kw. 53: *#10 exp Therapeutics/ 54: *#11 Treatment Outcome.ti.,ab.,kw. 55: *#12 exp Treatment Outcome/ 56: *#13 Outpatient.ti.,ab.,kw. 57: *#14 Clinic*.ti.,ab.,kw. 58; *#15 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9* 59; *#16 #10 OR #11* 60; *#17 #12* 61; *#18 #13* 62; *#19 #14* 63; *#20 #15 AND #16* 64; *#21 #20 AND #17* 65; *#22 #21 AND #18* 66; *#23 #22 AND #19* 67; Search date = 26th June 2018. 68: ### Study selection process 69: #### Identification 70 Title/abstract screening: 71 Two independent reviewers will screen titles/abstracts identified through electronic database searches against inclusion criteria outlined above. 72 Full-text screening: 73 Two independent reviewers will screen full-text articles identified as potentially relevant studies through title/abstract screening process using inclusion criteria outlined above. 74 #### Selection 75 Eligibility assessment: Two independent reviewers will assess eligibility of full-text articles identified through full-text screening process using inclusion criteria outlined above. 76 Included/excluded articles: Any disagreements between two independent reviewers during eligibility assessment process resolved by consensus discussion third reviewer if necessary. 77 #### Data collection process 78 Data extraction: Two independent reviewers will extract data from included full-text articles using standardized data extraction forms developed by authors before any disagreements resolved by consensus discussion third reviewer if necessary. 79 ### Data items 80 Study characteristics including title authors year country journal language study design sample size setting intervention comparator outcome measurement tool follow-up duration etcetera. 81 Participant characteristics including age gender race ethnicity religion socioeconomic status marital status employment status etcetera. 82 Intervention/exposure characteristics including type duration frequency intensity setting provider etcetera. 83 Comparator/control group characteristics including type duration frequency intensity setting provider etcetera. 84 Outcome characteristics including type duration frequency intensity setting provider etcetera. 85 Adverse events/complications characteristics including type duration frequency intensity severity outcome management follow-up duration etcetera. 86 ### Risk of bias assessment 87 Two independent reviewers will assess risk bias included full-text articles using appropriate tools developed by authors before any disagreements resolved by consensus discussion third reviewer if necessary. 88 Randomized controlled trials RCTs assessed risk bias using Cochrane Collaboration’s tool risk bias http://training.cochrane.org/handbook/current/chapter_08.pdf. 89 Non-randomized controlled trials non-RCT